C43H53NO14
807.9 g/mol
Ingrediente ativo (API)Perigo
Docetaxel
CAS114977-28-5EC601-339-2
Categoria
Ingrediente ativo (API)
Classe do Composto
Produto natural
Uso Principal
Matéria-prima farmacêutica
Docetaxel is an active pharmaceutical ingredient used in the manufacturing of medications. It is a complex organic compound with multiple hydroxyl and ester groups.
Antineoplastic agentTubulin modulatorPharmaceutical manufacturing raw material
Escopo do conteúdo: As informações desta página dizem respeito à identificação química e aos contextos de fornecimento industrial, pesquisa e produção. Não constituem alegação terapêutica, aconselhamento médico ou instruções de uso de medicamentos.
Adquirindo ou fornecendo este composto?
Publique seu inventário ou uma solicitação de compra
CAS 114977-28-5
Compostos relacionados
ForteMesma estrutura base
Docetaxel trihydrate
CAS148408-66-6
active pharmaceutical ingredient
ForteEstrutura similarSimilaridade 0.89
Docetaxal
CAS125354-16-7
active pharmaceutical ingredient
ForteEstrutura similarSimilaridade 0.86
10-Deacetyltaxol
CAS78432-77-6
antineoplastic microtubule stabilizing agent
SimilarEstrutura similarSimilaridade 0.79
((1S,2S,3R,4S,7R,9S,10S,12R,15S)-4-acetyloxy-1-hydroxy-15-((2R,3S)-2-hydroxy-3-((2-methylpropan-2-yl)oxycarbonylamino)-3-phenylpropanoyl)oxy-9,12-dimethoxy-10,14,17,17-tetramethyl-11-oxo-6-oxatetracyclo(11.3.1.03,10.04,7)heptadec-13-en-2-yl) benzoate;propan-2-one
CAS1426815-65-7
active pharmaceutical ingredient
SimilarEstrutura similarSimilaridade 0.79
Cabazitaxel
CAS183133-96-2
active pharmaceutical ingredient
ReferênciaMesma categoria
Mephobarbital
CAS115-38-8
anticonvulsant active pharmaceutical ingredient
ReferênciaMesma categoria
Parametadione
CAS115-67-3
anticonvulsant active pharmaceutical ingredient
ReferênciaMesma categoria
Ambenonium chloride
CAS115-79-7
cholinesterase inhibitor active pharmaceutical ingredient
Referência de Segurança
Perigo
H315Causes skin irritation
H319Causes serious eye irritation
H341Suspected of causing genetic defects
H351Suspected of causing cancer
H360May damage fertility or the unborn child
H361Suspected of damaging fertility or the unborn child
H362May cause harm to breast-fed children
H372Causes damage to organs through prolonged or repeated exposure
Identificadores
Nome IUPAC
[(1S,2S,3R,4S,7R,9S,10S,12R,15S)-4-acetyloxy-1,9,12-trihydroxy-15-[(2R,3S)-2-hydroxy-3-[(2-methylpropan-2-yl)oxycarbonylamino]-3-phenylpropanoyl]oxy-10,14,17,17-tetramethyl-11-oxo-6-oxatetracyclo[11.3.1.03,10.04,7]heptadec-13-en-2-yl] benzoate
InChIKey
ZDZOTLJHXYCWBA-VCVYQWHSSA-N
SMILES
CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O
Sinônimos (55)
- BEIZRAY
- DOCIVYX
- TXL
- Anhydrous Docetaxel, European Pharmacopoeia (EP)
- Docetaxel (JAN/INN)
- Docetaxolum [INN-Latin]
- Anhydrous Docetaxel
- Anhydrous Docetaxel CRS
- BIND 014
- DOCETAXEL MYLAN
- DOCETAXEL TEVA PHARMA
- Docecad
- Docefrez
- Docetaxel (Standard)
- Docetaxel (as trihydrate)
- Docetaxel - Bio-X trade mark
- Docetaxel Accord
- Docetaxel Kabi
- Docetaxel Teva
- Docetaxel Winthrop
- Docetaxel anhydrous
- Docetaxel intermediate
- Docetaxel, Trihydrate
- Docetaxol
- Docetaxolum
- EmDOC
- Taxceus
- Taxoel
- Taxotere
- Taxotere (Aventis)
- Taxotere (TN)
- docetaxel
- docetaxel 114977-28-5
- docetaxelum
- taxotel